SIMULECT 20 MG PÓ LIOF INJ CT FA VD TRANS

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1006800010072
  • GGREM 526518070093607
  • Código de barras 7896261021174

O que a fonte publica

Detentor do registro
NOVARTIS BIOCIENCIAS S.A
Princípios ativos
BASILIXIMAB
Embalagem
20 MG PÓ LIOF INJ CT FA VD TRANS
Tipo de produto
Novo
Classe terapêutica
L4C - INIBIDORES DA INTERLEUCINA

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:526518070093607
{
  "name": "SIMULECT 20 MG PÓ LIOF INJ CT FA VD TRANS",
  "holder": "NOVARTIS BIOCIENCIAS S.A",
  "stripe": null,
  "barcodes": [
    "7896261021174"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "526518070093607",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "56.994.502/0001-30",
  "priceRegime": "Regulado",
  "productName": "SIMULECT",
  "productType": "Novo",
  "hospitalOnly": true,
  "presentation": "20 MG PÓ LIOF INJ CT FA VD TRANS",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "7554.17",
    "icms-12": "8584.29",
    "icms-17": "9101.41",
    "icms-18": "9212.40",
    "icms-19": "9326.14",
    "icms-20": "9442.71",
    "icms-21": "9562.24",
    "icms-22": "9684.83",
    "icms-23": "9810.61",
    "icms-17.5": "9156.57",
    "icms-19.5": "9384.06",
    "icms-20.5": "9502.10",
    "icms-22.5": "9747.32",
    "icms-12-alc": "8481.27",
    "icms-17-alc": "8992.19",
    "icms-18-alc": "9101.85",
    "icms-19-alc": "9214.22",
    "icms-20-alc": "9329.39",
    "icms-21-alc": "9447.49",
    "icms-22-alc": "9568.61",
    "icms-23-alc": "9692.88",
    "withoutTaxes": "7463.52",
    "icms-17.5-alc": "9046.69",
    "icms-19.5-alc": "9271.45",
    "icms-20.5-alc": "9388.07",
    "icms-22.5-alc": "9630.35"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "BASILIXIMAB",
  "targetSpecies": [],
  "consumerPrices": null,
  "invalidBarcodes": [],
  "activeSubstances": [
    "BASILIXIMAB"
  ],
  "therapeuticClass": "L4C - INIBIDORES DA INTERLEUCINA",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1006800010072",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "L4C",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:526518070093607"